MZT(株)ゼブラフィッシュ創薬研究所

  • HOME
  • 研究開発
  • メンバー
  • アルバム
  • リンク
  • 研究員募集
  • アクセス
  • HOME
  • >
  • 研究員募集
  • >
  • 詳細

最近の記事

2025/06/12
本日大学院生野本氏の学位論文公開審査会
2025/06/10
今鉄男先生のウイーン大学だより
2025/05/02
新規蛍光色素ZMB741によるポドサイトパチー治療薬スクリーニング
2025/04/23
Screening of a New Fluorescent Dye, ZMB741, for the Treatment of Podocytopathy
2025/02/21
新しいoncocardionephrologyの展開
2025/01/01
DXAIゼブラフィッシュ創薬セミナーのご案内
2024/10/01
大学院生募集中 2024年10月16日(水)ー18日(金)
2024/07/01
患者がん移植ゼブラフィシュモデルの個別化医療戦略
2024/06/20
Creation and application of a new high-throughput individual zebrafish nephrotoxicity screening system
2024/06/06
AI(人工知能)ゼブラフィッシュ創薬の新しい展開

一覧に戻る

2020/06/08
  • CiteULike
  • reddit
  • StumbleUpon
  • linkedin
  • Delicious
  • Mendeley
  • はてなブックマーク
  • Youtube
  • Google+
  • Twitter
  • Facebook

大学院生のゼブラフィッシュ創薬論文が出版されました。

A novel orexin antagonist from a natural plant was discovered using zebrafish behavioural analysis
M. YAMANAKA1, H. IWATA2, K. MASUDA2, M. ARAKI2, Y. OKUNO2,
M. OKAMURA1, J. KOIWA1, T. TANAKA1
1Department of Systems Pharmacology, Mie University, Graduate School of Medicine, Tsu, Mie, Japan
2Graduate School of Medicine, Kyoto University, Kyoto, Japan

Abstract. – OBJECTIVE: Phenotypic screening is one of the most practical approaches
to the identification of mediators of behaviour,
since it is difficult to model brain function in vitro, at a cellular level. We used a zebrafish (Danio rerio) behavioural assay to discover novel,
natural, neuroactive compounds.
MATERIALS AND METHODS: A zebrafish
behavioural assay was performed for seven
natural compounds, obtained from plants. The
behavioural profiles were compared to those of
known psychoactive drugs. We characterised a
natural compound exhibiting a behaviour profile
similar to that of suvorexant, using in silico, in
vitro and microarray expression analysis.
RESULTS: The behavioural analysis performed
in this study classified central nervous system
drugs according to their mechanism. Zebrafish
treated with a natural compound, 8b-(4'-Hydroxytigloyloxy) costunolide (8b), showed behaviour
profiles similar to those of zebrafish treated with
suvorexant, a known orexin antagonist. This behavioural assay was validated using in silico and
in vitro assays, which revealed that the new compound was a dual orexin receptor antagonist. In
addition, transcriptome analysis suggested that
8b might regulate the nuclear factor-κB (NF-κB)
related pathway.
CONCLUSIONS: We conclude that zebrafish
phenotypic screening, combined with in silico
assays and gene expression profiling, is a useful
strategy to discover and characterize novel therapeutic compounds, including natural products.

関連リンク

  • 三重大学メディカルゼブラフィッシュ研究センター
  • Department of Systems Pharmacology Mie University Graduate School of Medicine

関連ファイル

  • A novel orexin antagonist from a natural plant was discovered using zebrafish behavioural analysis